abrdn Life Sciences Investors - Common (HQL)

CUSIP: 87911K100

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / Common
Shares outstanding
29,948,325
Total 13F shares
3,204,169
Share change
+21,673
Total reported value
$60,229,278
Price per share
$18.79
Number of holders
57
Value change
+$400,395
Number of buys
30
Number of sells
20

Quarterly Holders Quick Answers

What is CUSIP 87911K100?
CUSIP 87911K100 identifies HQL - abrdn Life Sciences Investors - Common in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of abrdn Life Sciences Investors - Common (HQL) as of Q2 2018

As of 30 Jun 2018, abrdn Life Sciences Investors - Common (HQL) was held by 57 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,204,169 shares. The largest 10 holders included MORGAN STANLEY, NEEDHAM INVESTMENT MANAGEMENT LLC, RAYMOND JAMES & ASSOCIATES, FLAGSHIP HARBOR ADVISORS, LLC, WELLS FARGO & COMPANY/MN, Invesco Ltd., COHEN & STEERS INC, Claraphi Advisory Network, LLC, WOLVERINE ASSET MANAGEMENT LLC, and LPL Financial LLC. This page lists 57 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.